Table 2.

Cytofluorimetric classes in all studied groups (mean ± SE): nonmacrovascular neuropathic diabetic patients without foot lesions (N); nonmacrovascular neuropathic diabetic patients with foot lesions (N1); macrovascular neuropathic diabetic patients with ulcers/lesions/osteomyelitis of the lower limbs (N2). Healthy controls (C).

	C (8)	N (14)	N1 (20)	N2 (28)
CD34+	515 ± 57	235 ± 18∗#	369 ± 34∗°	280 ± 24∗
CD133+	1970 ± 268	497 ± 81∗∗	686 ± 80∗∗	508 ± 75∗∗
CD34+45−	41 ± 5∧	21 ± 3	51 ± 9∧	41 ± 3∧
CD34+31+	273 ± 59∧∧	70 ± 9	175 ± 34∧	132 ± 19∧
CD133+31+	829 ± 112	248 ± 69∗∗	339 ± 53∗∗	269 ± 51∗∗
CD133+KDR+	122 ± 34	16 ± 5∗∗	26 ± 6∗∗	26 ± 10∗∗

*C  versus N, N1, N2 P < 0.03; ^#N versus N1 P < 0.004; °N1 versus N2 P < 0.03; ^∗∗C  versus N, N1, N2 P < 0.0006;  ^∧N versus N1, N2, C  P < 0.04; ^∧∧N2 versus C  P < 0.005.